IL10 and neoplasm: Recently, it has been demonstrated that blocking IL-10 concomitantly with immunization using Toll like receptor agonist inhibits tumour growth in a human papillomavirus E7 transformed TC-1 tumour mouse model, similar to a long E7 peptide/IFA vaccine that is effective against HPV infection related pre-cancer [11].